发明名称 Mature dendritic cell compositions and methods for culturing same
摘要 This invention provides methods to prepare and use immunostimulatory cells for enhancing an immune response. The invention provides a method for preparing mature dendritic cells (DCs), comprising the sequential steps of: (a) signaling isolated immature dendritic cells (iDCs) with a first signal comprising an interferon gamma receptor (IFN-γR) agonist and/or a tumor necrosis factor alpha receptor (TNF-αR) agonist to produce signaled dendritic cells; and (b) signaling said signaled dendritic cells with a second transient signal comprising an effective amount of a CD40 agonist to produce CCR7+ mature dendritic cells. Also provided by this invention are enriched populations of dendritic cells prepared by the methods of the invention. Such dendritic cells have enhanced immunostimulatory properties and increased IL-12 secretion and/or decreased IL-10 secretion. CD40 signaling can be initiated by one or more of polypeptide translated from an exogenous polynucleotide encoding CD40L (e.g., mRNA or DNA), an agonistic antibody to CD40 receptor or by CD40 ligand polypeptide. The enriched populations can be further modified by the administration of an immunogen to the DC. The DC will take up and process the immunogen on its cell surface.
申请公布号 US9523077(B2) 申请公布日期 2016.12.20
申请号 US201313941627 申请日期 2013.07.15
申请人 Argos Therapeutics, Inc. 发明人 Healey Don;Tcherepanova Irina;Adams Melissa;DeBenedette Mark
分类号 C12N15/87;C12N5/00;C12N5/071;A61K39/00;C12N5/02;A01N63/00;A61K48/00;C12N5/0784 主分类号 C12N15/87
代理机构 Sterne, Kessler, Goldstein & Fox P.L.L.C. 代理人 Sterne, Kessler, Goldstein & Fox P.L.L.C.
主权项 1. A method for preparing mature dendritic cells (DCs), comprising the sequential steps of: a. culturing isolated immature dendritic cells (iDCs) in culture medium comprising an interferon gamma receptor (IFN-γR) agonist and a TNF-αR agonist to produce CD83+ mature DCs; and b. cotransfecting said CD83+ mature DCs with mRNA encoding a CD40L polypeptide consisting of amino acid residues 21-261 of SEQ ID NO:2 and mRNA encoding an antigen approximately 12 to 30 hour after initiating step (a) to produce CD83+ CCR7+ mature DCs.
地址 Durham NC US